Back to HomeBeta

ICD-10 Coding for Carcinomatosis(C78.6, C80.1)

Complete ICD-10-CM coding and documentation guide for Carcinomatosis. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Peritoneal CarcinomatosisMetastatic Peritoneal Cancer

Related ICD-10 Code Ranges

Complete code families applicable to Carcinomatosis

C78-C79Primary Range

Secondary malignant neoplasms

This range includes codes for secondary malignant neoplasms, including peritoneal carcinomatosis.

Malignant neoplasm of retroperitoneum and peritoneum

This range includes primary malignant neoplasms of the peritoneum, which must be differentiated from secondary neoplasms.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C78.6Secondary malignant neoplasm of retroperitoneum and peritoneumUse when there is a confirmed secondary malignant neoplasm in the peritoneum.
  • Imaging showing peritoneal thickening or nodularity
  • Biopsy confirming metastatic adenocarcinoma
C80.1Malignant (primary) neoplasm, unspecifiedUse when the primary site of the malignancy is unknown.
  • Lack of documentation specifying the primary site

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for peritoneal carcinomatosis

Essential facts and insights about Carcinomatosis

The ICD-10 code for peritoneal carcinomatosis is C78.6, used for secondary malignant neoplasm of the peritoneum.

Primary ICD-10-CM Codes for carcinomatosis

Secondary malignant neoplasm of retroperitoneum and peritoneum
Billable Code

Decision Criteria

clinical Criteria

  • Presence of metastatic disease in the peritoneum confirmed by imaging and pathology.

coding Criteria

  • Primary malignancy must be coded if known.

Applicable To

  • Peritoneal carcinomatosis

Excludes

  • Primary peritoneal carcinoma (C48.2)

Clinical Validation Requirements

  • Imaging showing peritoneal thickening or nodularity
  • Biopsy confirming metastatic adenocarcinoma

Code-Specific Risks

  • Incorrectly using without a primary malignancy code

Coding Notes

  • Ensure documentation specifies the primary site if known.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Encounter for antineoplastic chemotherapy

Z51.11
Use when the encounter is primarily for chemotherapy treatment.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Malignant neoplasm of peritoneum, unspecified

C48.2
Use C48.2 for primary peritoneal cancer without a known primary elsewhere.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Carcinomatosis to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C78.6.

Impact

Clinical: May lead to inappropriate treatment decisions., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims.

Mitigation Strategy

Ensure documentation reflects current treatment status., Use active treatment codes when applicable.

Impact

Reimbursement: May lead to incorrect DRG assignment and reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate representation of the patient's condition.

Mitigation Strategy

Always link to the primary malignancy code.

Impact

Primary malignancy codes must precede secondary codes unless the primary is unknown.

Mitigation Strategy

Review coding guidelines and ensure proper sequencing.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Carcinomatosis, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Carcinomatosis

Use these documentation templates to ensure complete and accurate documentation for Carcinomatosis. These templates include all required elements for proper coding and billing.

Oncology follow-up visit

Specialty: Oncology

Required Elements

  • Patient history
  • Current treatment plan
  • Imaging results
  • Pathology findings

Example Documentation

Patient presents for follow-up of metastatic breast cancer with peritoneal carcinomatosis. Imaging shows stable disease. Continue current chemotherapy regimen.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Patient has cancer.
Good Documentation Example
Patient has metastatic breast cancer with peritoneal carcinomatosis, currently on paclitaxel.
Explanation
The good example provides specific details about the cancer type, location, and treatment.

Need help with ICD-10 coding for Carcinomatosis? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more